Insmed
INSM
INSM
223 hedge funds and large institutions have $2.89B invested in Insmed in 2022 Q1 according to their latest regulatory filings, with 32 funds opening new positions, 89 increasing their positions, 70 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
2.21% more ownership
Funds ownership: 104.19% → 106.4% (+2.2%)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
13% less capital invested
Capital invested by funds: $3.31B → $2.89B (-$418M)
Holders
223
Holding in Top 10
3
Calls
$3.96M
Puts
$1.65M
Top Buyers
| 1 | +$18.7M | |
| 2 | +$18M | |
| 3 | +$15.4M | |
| 4 |
RCMNY
Rubric Capital Management (New York)
New York
|
+$15.1M |
| 5 |
FFM
Fairmount Funds Management
West Conshohocken,
Pennsylvania
|
+$14.9M |
Top Sellers
| 1 | -$31M | |
| 2 | -$28.8M | |
| 3 | -$15.8M | |
| 4 |
PBA
Paradigm Biocapital Advisors
New York
|
-$10.7M |
| 5 |
SI
Sofinnova Investments
Menlo Park,
California
|
-$10.2M |